Fulcrum Neuroscience’s co-founder and CTO Tom Paterson was invited to present the company's latest research identifying cholesterol dyshomeostasis as a key driver of Alzheimer's Disease at the 2024 NIH Alzheimer's Research Summit. You can see his presentation below.
Links to Content